History of apoaequorin

Apoaequorin (Pronounced: ā-poe-ē-kwôr-ĭn) was first discovered in 1962 in glowing jellyfish. Turns out that apoaequorin caused the jellyfish to glow when bound to calcium ions. The Princeton professor who discovered Apoaequorin and his colleagues who helped develop the research helped form the foundation for the research that led to the development of Prevagen. Prevagen does not cause any glowing!

Quincy Bioscience and Apoaequorin



Jellyfish in Motion

Founded in June of 2004 and based in Madison, Wisconsin, Quincy Bioscience is a biotechnology company focused on the discovery, development, and commercialization of novel technologies to address cognitive issues and other normal health challenges such as mild memory loss associated with aging. The core technology of the company is the innovative application of Apoaequorin. Using Apoaequorin, originally discovered in jellyfish in the early 1960’s, the company focuses on mild memory loss associated with aging.

Apoaequorin originally comes from a species of jellyfish called Aequorea victoria — a bioluminescent organism with one of the simplest nervous systems. Quincy Bioscience is the first to utilize apoaequorin as a tool in the support of the brain in the human body.*